Literature DB >> 19832823

Aseptic meningitis and ischaemic stroke in Fabry disease.

O Lidove1, M-P Chauveheid, C Caillaud, R Froissart, L Benoist, S Alamowitch, S Doan, R Szalat, N Baumann, J-F Alexandra, P Lavallée, I Klein, F Vuillemet, F Sedel, K Sacré, Y Samson, E Roullet, T Papo.   

Abstract

BACKGROUND: Fabry disease (OMIM 301 500) is an X-linked lysosomal storage disease. Neurological symptoms in Fabry disease mainly include stroke, acroparesthesia, cranial nerve palsies and autonomic dysfunction. We report on aseptic meningitis in Fabry patients.
METHODS: Clinical analysis, brain magnetic resonance imaging, cerebrospinal fluid analysis, treatment and outcome data were analysed in three cases of meningitis associated with Fabry disease.
FINDINGS: Mean age at meningitis onset was 26.6 (24-28) years. Headache was present in all cases and fever in two cases. Meningitis was always diagnosed before Fabry disease. A familial history of Fabry disease was present in two cases. Non-neurological symptoms caused by Fabry disease were present in all cases. All patients also suffered stroke and sensorineural hearing loss. Cerebrospinal fluid (CSF) analysis showed pleocytosis (mean, 36; range: 8-76 cells/mm(3)) and a high protein level (mean, 63; range, 47-70 mg/dl). C-reactive protein blood levels and erythrocyte sedimentation rate were raised. Diagnosis was assessed by low alpha-galactosidase A dosage and/or gene mutation analysis in all cases. All patients were treated with enzyme replacement therapy (ERT). In two cases, lumbar puncture was repeatedly performed and there was no normalisation of CSF under ERT alone, at 9 and 24 months of follow-up, respectively. One patient who suffered intracranial hypertension was treated efficiently with steroids, associated with azathioprine. The fact that Fabry disease could be an auto-inflammatory disorder is discussed.
INTERPRETATION: Fabry disease may cause aseptic meningitis.

Entities:  

Mesh:

Year:  2009        PMID: 19832823     DOI: 10.1111/j.1742-1241.2009.02115.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  5 in total

1.  Aseptic meningitis in Fabry disease due to a novel GLA variant: an expanded phenotype?

Authors:  Paulo Ribeiro Nóbrega; João Lucas Araújo Morais; Alliane Milliane Ferreira; Alisson Dantas de Medeiros; Beatrice Araújo Duarte; Deborah Moreira Rangel; Fabrício Oliveira Lima; Anderson Rodrigues Brandão de Paiva; Luciana Paim-Marques; Fernando Kok; André Luiz Santos Pessoa; Pedro Braga-Neto; Fernanda Martins Maia Carvalho
Journal:  Neurol Sci       Date:  2022-09-12       Impact factor: 3.830

2.  Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy.

Authors:  Alessandro Salviati; Alessandro P Burlina; Walter Borsini
Journal:  Neurol Sci       Date:  2010-03-19       Impact factor: 3.307

3.  Fabry disease - underestimated in the differential diagnosis of multiple sclerosis?

Authors:  Tobias Böttcher; Arndt Rolfs; Christian Tanislav; Andreas Bitsch; Wolfgang Köhler; Jens Gaedeke; Anne-Katrin Giese; Edwin H Kolodny; Thomas Duning
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

4.  Clinical-Pathological Conference Series from the Medical University of Graz : Case No 153: A 55-year-old woman with atypical multiple sclerosis and irritable bowel syndrome.

Authors:  Elisabeth Fabian; Dietmar Schiller; Hermann Toplak; Michaela Brunner-Krainz; Franz Fazekas; Rainer Schoefl; Guenter J Krejs
Journal:  Wien Klin Wochenschr       Date:  2017-11-21       Impact factor: 1.704

5.  Fabry disease with acute cerebral infarction onset in a young patient.

Authors:  Ya-Nan Zhang; Zhen-Ni Guo; Hong-Wei Zhou; Ying-Ying Cheng; Jia-Chun Feng; Zan Wang
Journal:  Chin Med J (Engl)       Date:  2019-02       Impact factor: 2.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.